Phibro Animal Health
PAHC
130 hedge funds and large institutions have $274M invested in Phibro Animal Health in 2023 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 51 reducing their positions, and 15 closing their positions.
74% more call options, than puts
Call options by funds: $82K | Put options by funds: $47K
6% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 51
1.61% less ownership
Funds ownership: 99.81% → 98.2% (-1.6%)
2% less funds holding
Funds holding: 133 → 130 (-3)
12% less capital invested
Capital invested by funds: $311M → $274M (-$37.3M)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
+$3.04M |
| 2 |
BlackRock
New York
|
+$1.08M |
| 3 |
BIP
Brandes Investment Partners
La Jolla,
California
|
+$1.04M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.01M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$858K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$3.12M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$1.51M |
| 3 |
Pzena Investment Management
New York
|
-$1.36M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$1.32M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.12M |
PAHC Hedge Fund Activity: Q2 2023 in Review
130 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q2 2023, worth a combined $274M — down 12% from $311M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of PAHC and 12 opened new positions — a net loss of 3 holders — while 51 trimmed existing stakes and 48 added.
The largest buyer was Brandywine Global Investment Management, opening a new position worth an estimated $3.04M. The largest seller was Goldman Sachs, cutting an estimated $3.12M.
- 130 institutional investors held Phibro Animal Health (PAHC) as of Q2 2023, down from 133 in Q1 2023.
- Funds reported $274M of Phibro Animal Health stock for Q2 2023, down 12% quarter-over-quarter.
- 12 funds opened new Phibro Animal Health positions in Q2 2023 and 15 closed out, a net change of -3 holders.
- The largest Phibro Animal Health buyer in Q2 2023 was Brandywine Global Investment Management, an estimated $3.04M added.
- The largest Phibro Animal Health seller in Q2 2023 was Goldman Sachs, an estimated $3.12M sold.
Based on aggregated 13F filings for Q2 2023.